Translating Research into Practice

Translational Centers of Excellence aim to find solutions to the most pressing issues confronting cancer patients.

Profile of Chi Van Dang, MD, PhD

Chi Van Dang, MD, PhD

Director, Abramson Cancer Center of the University of Pennsylvania

John H. Glick, M.D. Abramson Cancer Center Director's Professor

What is a Translational Center of Excellence?

Changing the Future of Cancer Research and Care

When Director Chi V. Dang, MD, PhD, joined Penn Medicine’s Abramson Cancer Center, one of his key priorities was to create flagship medical programs that would bring together experts from diverse fields to address major challenges in cancer care.

He invited faculty from the Penn community to form teams and develop multidisciplinary, disease-specific Translational Centers of Excellence (TCEs) aimed at finding solutions to the most pressing issues confronting cancer patients.

An entirely new approach to large-scale, high-impact research, the ultimate goal of TCEs is to identify and support projects that will become flagship programs for patients seeking leading-edge, personalized cancer care.

Following an extensive application and scientific review process, the following TCEs were selected for funding:

Fueling Innovation and Propelling Discovery

Translational Centers of Excellence are narrowing the gap between the clinic and the laboratory, accelerating the pace of discoveries that will help today’s patients become—and remain—cancer-free. They bring together the most brilliant minds from across the Penn system, from basic scientists to engineers, inspiring one another to work together to solve cancer’s most complex challenges — and create possibilities that have never been dreamed.